Co-Founders
Dr. Krzysztof Reiss, Ph.D. — Co-Founder & CSO
Tenured Professor at LSU Health Sciences Center and Director of Neurological Cancer Research at the Stanley S. Scott Cancer Center. Author of 170+ peer-reviewed publications. Recipient of multiple NIH/NCI R01 grants. Co-inventor on both WayPath patents with 25+ years in cancer cell signaling, energy metabolism, and brain tumor drug development.
Dr. Branko Jursic, Ph.D. — Co-Founder & Lead Chemist
Tenured Professor at the University of New Orleans, Department of Chemistry. 25+ years in synthetic medicinal chemistry. 72 peer-reviewed publications and 12 patents. Expert in computational drug design using CNS-MPO and BBB_Score algorithms. Designed all 100+ WayPath compound variants and leads GMP synthesis with Singota Solutions.
Strategic Partners
LSU Health Sciences Center
Core scientific partner. Home of WayPath's foundational research and canine clinical trial collaboration through LSU Vet Med.
NCI NExT Program
Introductory meeting completed July 2024. NCI application in progress.
NIH STTR Grant
Competitive NIH Phase I STTR grant awarded Q4 2022. Phase II application submitted September 2025.
Singota Solutions
GMP-certified manufacturing partner (Indiana) for PP211 oral formulation development and scale-up.